Archyde The Food and Drug Administration experienced a period of significant internal debate and external scrutiny under the leadership of Dr. Vinay Prasad, who recently announced his departure next month. His… You can read the full story here: FDA’s Vinay Prasad Resigns: Controversy & Criticism Explained. Source link
Archyde Washington D.C. – A recent forum hosted by the Pharmaceutical Research and Manufacturers of America (PhRMA) revealed a notable divergence in perspectives among key figures within the Biden administration, particularly… You can read the full story here: RFK Jr. Team Divided on Pharma & Vaccines at PhRMA Forum. Source link
A new experimental cholesterol-lowering pill and recent advances in oral diabetes treatments are reinforcing a broader shift toward earlier, less invasive management of cardiometabolic disease, as drugmakers and clinicians focus on prevention, adherence, and risk reduction in high-risk populations. “There are other pills that patients can add to their statins, but none come close to … Read more
Archyde Artificial Intelligence Startup Expert intelligence Secures $4.7 Million in Seed Funding San Francisco, california – Expert Intelligence, a pioneering start-up focused on Artificial Intelligence solutions for regulated laboratory environments, has… You can read the full story here: AI Startup Expert Intelligence Raises $4.7 Million to Automate Regulated Laboratory Data Analysis with AI. Source link
Cancer Diagnosis, Accelerated by AI January 31, 2026 | Saturday | Analysis | By Ayesha Siddiqui Cancer remains a leading cause of death worldwide, with Asia bearing a disproportionate burden. In 2020, the region accounted for nearly half of global cancer cases and over 58 per cent of cancer-related deaths. Lung, breast, and colorectal cancers … Read more
Micah T. Prochaska, MD, MSc | Image Credit: University of Chicago School of Medicine A recent secondary analysis of data from the Myocardial Ischemia and Transfusion (MINT) trial has found no difference in quality of life (QOL) outcomes between liberal versus restrictive transfusion strategies in patients with myocardial infarction (MI) and anemia.1 Thanks to advances … Read more
New findings from a real-world study has demonstrated long-term safety of secukinumab in people with psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing spondylitis (AS).1 “Patients with immune-mediated inflammatory diseases such as PsO, PsA and AS, require prolonged treatment and are more susceptible to developing AEs as observed in clinical studies and case reports. Therefore, there … Read more
Key Points FDA approves MenQuadfi for infants 6 weeks to 23 months. menquadfi protects against invasive meningococcal disease. Vaccine is given as a 4-dose or 2-dose series, depending on age. Meningococcal infections can cause meningitis and bloodstream infections. FDA Approves MenQuadfi Vaccine for Infants, Expanding Meningococcal Disease Protection Updated May 29, 2025 The […] … Read more
Nicholas Todhunter, DO Credit: AHN The neuroscience program at AHN Saint Vincent Hospital plays a vital role in providing advanced neurological care to patients in the Erie region — reducing the need to travel to a major city for many conditions. Without this local access, many would face delays in receiving life-saving or quality-of-life-enhancing treatment. … Read more
Adults aged 80 and older experience the highest prevalence of cardiovascular disease, yet the optimal blood pressure targets for this group have been unclear in clinical guidelines. Now, a new study from Yale School of Medicine (YSM) suggests that intensive blood pressure management may offer important benefits for very elderly patients. As the American population … Read more